X-rays for drug discovery
from Translational and Clinical
Professor Frank von Delft works to ensure that X-ray structures can serve as a routine and predictive tool for generating novel chemistry for targeting proteins. In the process of drug discovery, X-ray crystallography is the most sensitive way to find out which compounds bind to a target protein. Recent advances in technology allow researchers to test many more compounds, much more rapidly. The ultimate aim is to bring much needed new treatments to patients.
Embed this episode
No transcript yet.
Similar podcasts
Frequently asked questions
How long is this episode of Translational and Clinical?
This episode is 7 minutes long.
When was this Translational and Clinical episode published?
This episode was published on September 23, 2016.
Can I download this Translational and Clinical episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.